Global Long-Acting Reversible Contraception(LARC) Market Growth 2026-2032
The global Long-Acting Reversible Contraception(LARC) market size is predicted to grow from US$ 1326 million in 2025 to US$ 2008 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
Long-acting reversible pregnancy (LARC) is a birth control method that provides long-term pregnancy prevention. LARC can provide protection for three to 10 years or more.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Long-Acting Reversible Contraception(LARC) Industry Forecast” looks at past sales and reviews total world Long-Acting Reversible Contraception(LARC) sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-Acting Reversible Contraception(LARC) sales for 2026 through 2032. With Long-Acting Reversible Contraception(LARC) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Acting Reversible Contraception(LARC) industry.
This Insight Report provides a comprehensive analysis of the global Long-Acting Reversible Contraception(LARC) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-Acting Reversible Contraception(LARC) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Acting Reversible Contraception(LARC) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Acting Reversible Contraception(LARC) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Acting Reversible Contraception(LARC).
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Acting Reversible Contraception(LARC) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Long-acting reversible pregnancy (LARC) is a birth control method that provides long-term pregnancy prevention. LARC can provide protection for three to 10 years or more.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Long-Acting Reversible Contraception(LARC) Industry Forecast” looks at past sales and reviews total world Long-Acting Reversible Contraception(LARC) sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-Acting Reversible Contraception(LARC) sales for 2026 through 2032. With Long-Acting Reversible Contraception(LARC) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Acting Reversible Contraception(LARC) industry.
This Insight Report provides a comprehensive analysis of the global Long-Acting Reversible Contraception(LARC) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-Acting Reversible Contraception(LARC) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Acting Reversible Contraception(LARC) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Acting Reversible Contraception(LARC) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Acting Reversible Contraception(LARC).
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Acting Reversible Contraception(LARC) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Intrauterine Devices (IUCs)
- Subcutaneous Implant
- Age 20~24 Years Old
- Age 25-34 Years Old
- Age 35~44 Years Old
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Merck
- Teva Pharmaceutical
- Allergan
- HRA Pharma
- Eurogine
- Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
- Wuxi Tianyi Medical Equipment Co., Ltd.
- SMB Corporation
- Shenyang Liren
- Tianjin Hejie Medical Equipment Co., Ltd.
- Cooper Companies
- AbbVie Allergan
- Organon
- Shanghai Dahua Pharmaceutical
- What is the 10-year outlook for the global Long-Acting Reversible Contraception(LARC) market?
- What factors are driving Long-Acting Reversible Contraception(LARC) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Long-Acting Reversible Contraception(LARC) market opportunities vary by end market size?
- How does Long-Acting Reversible Contraception(LARC) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-Acting Reversible Contraception(LARC) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-Acting Reversible Contraception(LARC) by Country/Region, 2021, 2025 & 2032
2.2 Long-Acting Reversible Contraception(LARC) Segment by Type
2.2.1 Intrauterine Devices (IUCs)
2.2.2 Subcutaneous Implant
2.2.3 Long-Acting Reversible Contraception(LARC) Sales by Type
2.2.3.1 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Long-Acting Reversible Contraception(LARC) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Type (2021-2026)
2.3 Long-Acting Reversible Contraception(LARC) Segment by Application
2.3.1 Age 20~24 Years Old
2.3.2 Age 25-34 Years Old
2.3.3 Age 35~44 Years Old
2.3.4 Other
2.3.5 Long-Acting Reversible Contraception(LARC) Sales by Application
2.3.5.1 Global Long-Acting Reversible Contraception(LARC) Sale Market Share by Application (2021-2026)
2.3.5.2 Global Long-Acting Reversible Contraception(LARC) Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-Acting Reversible Contraception(LARC) Breakdown Data by Company
3.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Company (2021-2026)
3.1.2 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company (2021-2026)
3.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Company (2021-2026)
3.2.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2021-2026)
3.2.2 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company (2021-2026)
3.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Company
3.4 Key Manufacturers Long-Acting Reversible Contraception(LARC) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-Acting Reversible Contraception(LARC) Product Location Distribution
3.4.2 Players Long-Acting Reversible Contraception(LARC) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY GEOGRAPHIC REGION
4.1 World Historic Long-Acting Reversible Contraception(LARC) Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-Acting Reversible Contraception(LARC) Market Size by Country/Region (2021-2026)
4.2.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-Acting Reversible Contraception(LARC) Sales Growth
4.4 APAC Long-Acting Reversible Contraception(LARC) Sales Growth
4.5 Europe Long-Acting Reversible Contraception(LARC) Sales Growth
4.6 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Growth
5 AMERICAS
5.1 Americas Long-Acting Reversible Contraception(LARC) Sales by Country
5.1.1 Americas Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026)
5.1.2 Americas Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026)
5.2 Americas Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026)
5.3 Americas Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Reversible Contraception(LARC) Sales by Region
6.1.1 APAC Long-Acting Reversible Contraception(LARC) Sales by Region (2021-2026)
6.1.2 APAC Long-Acting Reversible Contraception(LARC) Revenue by Region (2021-2026)
6.2 APAC Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026)
6.3 APAC Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-Acting Reversible Contraception(LARC) by Country
7.1.1 Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026)
7.1.2 Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026)
7.2 Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026)
7.3 Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Reversible Contraception(LARC) by Country
8.1.1 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026)
8.3 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-Acting Reversible Contraception(LARC)
10.3 Manufacturing Process Analysis of Long-Acting Reversible Contraception(LARC)
10.4 Industry Chain Structure of Long-Acting Reversible Contraception(LARC)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-Acting Reversible Contraception(LARC) Distributors
11.3 Long-Acting Reversible Contraception(LARC) Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY GEOGRAPHIC REGION
12.1 Global Long-Acting Reversible Contraception(LARC) Market Size Forecast by Region
12.1.1 Global Long-Acting Reversible Contraception(LARC) Forecast by Region (2027-2032)
12.1.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-Acting Reversible Contraception(LARC) Forecast by Type (2027-2032)
12.7 Global Long-Acting Reversible Contraception(LARC) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.1.3 Bayer Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.2.3 Merck Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Teva Pharmaceutical
13.3.1 Teva Pharmaceutical Company Information
13.3.2 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teva Pharmaceutical Main Business Overview
13.3.5 Teva Pharmaceutical Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.4.3 Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 HRA Pharma
13.5.1 HRA Pharma Company Information
13.5.2 HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.5.3 HRA Pharma Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 HRA Pharma Main Business Overview
13.5.5 HRA Pharma Latest Developments
13.6 Eurogine
13.6.1 Eurogine Company Information
13.6.2 Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.6.3 Eurogine Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Eurogine Main Business Overview
13.6.5 Eurogine Latest Developments
13.7 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
13.7.1 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Information
13.7.2 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.7.3 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Main Business Overview
13.7.5 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Latest Developments
13.8 Wuxi Tianyi Medical Equipment Co., Ltd.
13.8.1 Wuxi Tianyi Medical Equipment Co., Ltd. Company Information
13.8.2 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.8.3 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Wuxi Tianyi Medical Equipment Co., Ltd. Main Business Overview
13.8.5 Wuxi Tianyi Medical Equipment Co., Ltd. Latest Developments
13.9 SMB Corporation
13.9.1 SMB Corporation Company Information
13.9.2 SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.9.3 SMB Corporation Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 SMB Corporation Main Business Overview
13.9.5 SMB Corporation Latest Developments
13.10 Shenyang Liren
13.10.1 Shenyang Liren Company Information
13.10.2 Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.10.3 Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Shenyang Liren Main Business Overview
13.10.5 Shenyang Liren Latest Developments
13.11 Tianjin Hejie Medical Equipment Co., Ltd.
13.11.1 Tianjin Hejie Medical Equipment Co., Ltd. Company Information
13.11.2 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.11.3 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tianjin Hejie Medical Equipment Co., Ltd. Main Business Overview
13.11.5 Tianjin Hejie Medical Equipment Co., Ltd. Latest Developments
13.12 Cooper Companies
13.12.1 Cooper Companies Company Information
13.12.2 Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.12.3 Cooper Companies Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Cooper Companies Main Business Overview
13.12.5 Cooper Companies Latest Developments
13.13 AbbVie Allergan
13.13.1 AbbVie Allergan Company Information
13.13.2 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.13.3 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 AbbVie Allergan Main Business Overview
13.13.5 AbbVie Allergan Latest Developments
13.14 Organon
13.14.1 Organon Company Information
13.14.2 Organon Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.14.3 Organon Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Organon Main Business Overview
13.14.5 Organon Latest Developments
13.15 Shanghai Dahua Pharmaceutical
13.15.1 Shanghai Dahua Pharmaceutical Company Information
13.15.2 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.15.3 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Shanghai Dahua Pharmaceutical Main Business Overview
13.15.5 Shanghai Dahua Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-Acting Reversible Contraception(LARC) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-Acting Reversible Contraception(LARC) by Country/Region, 2021, 2025 & 2032
2.2 Long-Acting Reversible Contraception(LARC) Segment by Type
2.2.1 Intrauterine Devices (IUCs)
2.2.2 Subcutaneous Implant
2.2.3 Long-Acting Reversible Contraception(LARC) Sales by Type
2.2.3.1 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Long-Acting Reversible Contraception(LARC) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Type (2021-2026)
2.3 Long-Acting Reversible Contraception(LARC) Segment by Application
2.3.1 Age 20~24 Years Old
2.3.2 Age 25-34 Years Old
2.3.3 Age 35~44 Years Old
2.3.4 Other
2.3.5 Long-Acting Reversible Contraception(LARC) Sales by Application
2.3.5.1 Global Long-Acting Reversible Contraception(LARC) Sale Market Share by Application (2021-2026)
2.3.5.2 Global Long-Acting Reversible Contraception(LARC) Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-Acting Reversible Contraception(LARC) Breakdown Data by Company
3.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Company (2021-2026)
3.1.2 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company (2021-2026)
3.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Company (2021-2026)
3.2.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2021-2026)
3.2.2 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company (2021-2026)
3.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Company
3.4 Key Manufacturers Long-Acting Reversible Contraception(LARC) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-Acting Reversible Contraception(LARC) Product Location Distribution
3.4.2 Players Long-Acting Reversible Contraception(LARC) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY GEOGRAPHIC REGION
4.1 World Historic Long-Acting Reversible Contraception(LARC) Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-Acting Reversible Contraception(LARC) Market Size by Country/Region (2021-2026)
4.2.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-Acting Reversible Contraception(LARC) Sales Growth
4.4 APAC Long-Acting Reversible Contraception(LARC) Sales Growth
4.5 Europe Long-Acting Reversible Contraception(LARC) Sales Growth
4.6 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Growth
5 AMERICAS
5.1 Americas Long-Acting Reversible Contraception(LARC) Sales by Country
5.1.1 Americas Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026)
5.1.2 Americas Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026)
5.2 Americas Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026)
5.3 Americas Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Reversible Contraception(LARC) Sales by Region
6.1.1 APAC Long-Acting Reversible Contraception(LARC) Sales by Region (2021-2026)
6.1.2 APAC Long-Acting Reversible Contraception(LARC) Revenue by Region (2021-2026)
6.2 APAC Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026)
6.3 APAC Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-Acting Reversible Contraception(LARC) by Country
7.1.1 Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026)
7.1.2 Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026)
7.2 Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026)
7.3 Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Reversible Contraception(LARC) by Country
8.1.1 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026)
8.3 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-Acting Reversible Contraception(LARC)
10.3 Manufacturing Process Analysis of Long-Acting Reversible Contraception(LARC)
10.4 Industry Chain Structure of Long-Acting Reversible Contraception(LARC)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-Acting Reversible Contraception(LARC) Distributors
11.3 Long-Acting Reversible Contraception(LARC) Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY GEOGRAPHIC REGION
12.1 Global Long-Acting Reversible Contraception(LARC) Market Size Forecast by Region
12.1.1 Global Long-Acting Reversible Contraception(LARC) Forecast by Region (2027-2032)
12.1.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-Acting Reversible Contraception(LARC) Forecast by Type (2027-2032)
12.7 Global Long-Acting Reversible Contraception(LARC) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.1.3 Bayer Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.2.3 Merck Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Teva Pharmaceutical
13.3.1 Teva Pharmaceutical Company Information
13.3.2 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teva Pharmaceutical Main Business Overview
13.3.5 Teva Pharmaceutical Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.4.3 Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 HRA Pharma
13.5.1 HRA Pharma Company Information
13.5.2 HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.5.3 HRA Pharma Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 HRA Pharma Main Business Overview
13.5.5 HRA Pharma Latest Developments
13.6 Eurogine
13.6.1 Eurogine Company Information
13.6.2 Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.6.3 Eurogine Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Eurogine Main Business Overview
13.6.5 Eurogine Latest Developments
13.7 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
13.7.1 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Information
13.7.2 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.7.3 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Main Business Overview
13.7.5 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Latest Developments
13.8 Wuxi Tianyi Medical Equipment Co., Ltd.
13.8.1 Wuxi Tianyi Medical Equipment Co., Ltd. Company Information
13.8.2 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.8.3 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Wuxi Tianyi Medical Equipment Co., Ltd. Main Business Overview
13.8.5 Wuxi Tianyi Medical Equipment Co., Ltd. Latest Developments
13.9 SMB Corporation
13.9.1 SMB Corporation Company Information
13.9.2 SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.9.3 SMB Corporation Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 SMB Corporation Main Business Overview
13.9.5 SMB Corporation Latest Developments
13.10 Shenyang Liren
13.10.1 Shenyang Liren Company Information
13.10.2 Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.10.3 Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Shenyang Liren Main Business Overview
13.10.5 Shenyang Liren Latest Developments
13.11 Tianjin Hejie Medical Equipment Co., Ltd.
13.11.1 Tianjin Hejie Medical Equipment Co., Ltd. Company Information
13.11.2 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.11.3 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tianjin Hejie Medical Equipment Co., Ltd. Main Business Overview
13.11.5 Tianjin Hejie Medical Equipment Co., Ltd. Latest Developments
13.12 Cooper Companies
13.12.1 Cooper Companies Company Information
13.12.2 Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.12.3 Cooper Companies Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Cooper Companies Main Business Overview
13.12.5 Cooper Companies Latest Developments
13.13 AbbVie Allergan
13.13.1 AbbVie Allergan Company Information
13.13.2 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.13.3 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 AbbVie Allergan Main Business Overview
13.13.5 AbbVie Allergan Latest Developments
13.14 Organon
13.14.1 Organon Company Information
13.14.2 Organon Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.14.3 Organon Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Organon Main Business Overview
13.14.5 Organon Latest Developments
13.15 Shanghai Dahua Pharmaceutical
13.15.1 Shanghai Dahua Pharmaceutical Company Information
13.15.2 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.15.3 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Shanghai Dahua Pharmaceutical Main Business Overview
13.15.5 Shanghai Dahua Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-Acting Reversible Contraception(LARC) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-Acting Reversible Contraception(LARC) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intrauterine Devices (IUCs)
Table 4. Major Players of Subcutaneous Implant
Table 5. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 6. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Table 7. Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2021-2026)
Table 9. Global Long-Acting Reversible Contraception(LARC) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Long-Acting Reversible Contraception(LARC) Sale by Application (2021-2026) & (K Units)
Table 11. Global Long-Acting Reversible Contraception(LARC) Sale Market Share by Application (2021-2026)
Table 12. Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2021-2026)
Table 14. Global Long-Acting Reversible Contraception(LARC) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Long-Acting Reversible Contraception(LARC) Sales by Company (2021-2026) & (K Units)
Table 16. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company (2021-2026)
Table 17. Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company (2021-2026)
Table 19. Global Long-Acting Reversible Contraception(LARC) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Long-Acting Reversible Contraception(LARC) Producing Area Distribution and Sales Area
Table 21. Players Long-Acting Reversible Contraception(LARC) Products Offered
Table 22. Long-Acting Reversible Contraception(LARC) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Long-Acting Reversible Contraception(LARC) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Long-Acting Reversible Contraception(LARC) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Long-Acting Reversible Contraception(LARC) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Long-Acting Reversible Contraception(LARC) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2021-2026)
Table 35. Americas Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Long-Acting Reversible Contraception(LARC) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2021-2026)
Table 40. APAC Long-Acting Reversible Contraception(LARC) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Long-Acting Reversible Contraception(LARC)
Table 52. Key Market Challenges & Risks of Long-Acting Reversible Contraception(LARC)
Table 53. Key Industry Trends of Long-Acting Reversible Contraception(LARC)
Table 54. Long-Acting Reversible Contraception(LARC) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Long-Acting Reversible Contraception(LARC) Distributors List
Table 57. Long-Acting Reversible Contraception(LARC) Customer List
Table 58. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Long-Acting Reversible Contraception(LARC) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Long-Acting Reversible Contraception(LARC) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Long-Acting Reversible Contraception(LARC) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bayer Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 74. Bayer Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bayer Main Business
Table 76. Bayer Latest Developments
Table 77. Merck Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 79. Merck Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Merck Main Business
Table 81. Merck Latest Developments
Table 82. Teva Pharmaceutical Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 83. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 84. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Teva Pharmaceutical Main Business
Table 86. Teva Pharmaceutical Latest Developments
Table 87. Allergan Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 88. Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 89. Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Allergan Main Business
Table 91. Allergan Latest Developments
Table 92. HRA Pharma Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 93. HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 94. HRA Pharma Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. HRA Pharma Main Business
Table 96. HRA Pharma Latest Developments
Table 97. Eurogine Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 98. Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 99. Eurogine Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Eurogine Main Business
Table 101. Eurogine Latest Developments
Table 102. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 103. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 104. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Main Business
Table 106. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Latest Developments
Table 107. Wuxi Tianyi Medical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 108. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 109. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Wuxi Tianyi Medical Equipment Co., Ltd. Main Business
Table 111. Wuxi Tianyi Medical Equipment Co., Ltd. Latest Developments
Table 112. SMB Corporation Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 113. SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 114. SMB Corporation Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. SMB Corporation Main Business
Table 116. SMB Corporation Latest Developments
Table 117. Shenyang Liren Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 118. Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 119. Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Shenyang Liren Main Business
Table 121. Shenyang Liren Latest Developments
Table 122. Tianjin Hejie Medical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 123. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 124. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Tianjin Hejie Medical Equipment Co., Ltd. Main Business
Table 126. Tianjin Hejie Medical Equipment Co., Ltd. Latest Developments
Table 127. Cooper Companies Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 128. Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 129. Cooper Companies Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Cooper Companies Main Business
Table 131. Cooper Companies Latest Developments
Table 132. AbbVie Allergan Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 133. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 134. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. AbbVie Allergan Main Business
Table 136. AbbVie Allergan Latest Developments
Table 137. Organon Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 138. Organon Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 139. Organon Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Organon Main Business
Table 141. Organon Latest Developments
Table 142. Shanghai Dahua Pharmaceutical Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 143. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 144. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Shanghai Dahua Pharmaceutical Main Business
Table 146. Shanghai Dahua Pharmaceutical Latest Developments
Table 1. Long-Acting Reversible Contraception(LARC) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-Acting Reversible Contraception(LARC) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intrauterine Devices (IUCs)
Table 4. Major Players of Subcutaneous Implant
Table 5. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 6. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Table 7. Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2021-2026)
Table 9. Global Long-Acting Reversible Contraception(LARC) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Long-Acting Reversible Contraception(LARC) Sale by Application (2021-2026) & (K Units)
Table 11. Global Long-Acting Reversible Contraception(LARC) Sale Market Share by Application (2021-2026)
Table 12. Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2021-2026)
Table 14. Global Long-Acting Reversible Contraception(LARC) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Long-Acting Reversible Contraception(LARC) Sales by Company (2021-2026) & (K Units)
Table 16. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company (2021-2026)
Table 17. Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company (2021-2026)
Table 19. Global Long-Acting Reversible Contraception(LARC) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Long-Acting Reversible Contraception(LARC) Producing Area Distribution and Sales Area
Table 21. Players Long-Acting Reversible Contraception(LARC) Products Offered
Table 22. Long-Acting Reversible Contraception(LARC) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Long-Acting Reversible Contraception(LARC) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Long-Acting Reversible Contraception(LARC) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Long-Acting Reversible Contraception(LARC) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Long-Acting Reversible Contraception(LARC) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2021-2026)
Table 35. Americas Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Long-Acting Reversible Contraception(LARC) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2021-2026)
Table 40. APAC Long-Acting Reversible Contraception(LARC) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Long-Acting Reversible Contraception(LARC)
Table 52. Key Market Challenges & Risks of Long-Acting Reversible Contraception(LARC)
Table 53. Key Industry Trends of Long-Acting Reversible Contraception(LARC)
Table 54. Long-Acting Reversible Contraception(LARC) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Long-Acting Reversible Contraception(LARC) Distributors List
Table 57. Long-Acting Reversible Contraception(LARC) Customer List
Table 58. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Long-Acting Reversible Contraception(LARC) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Long-Acting Reversible Contraception(LARC) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Long-Acting Reversible Contraception(LARC) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bayer Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 74. Bayer Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bayer Main Business
Table 76. Bayer Latest Developments
Table 77. Merck Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 79. Merck Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Merck Main Business
Table 81. Merck Latest Developments
Table 82. Teva Pharmaceutical Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 83. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 84. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Teva Pharmaceutical Main Business
Table 86. Teva Pharmaceutical Latest Developments
Table 87. Allergan Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 88. Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 89. Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Allergan Main Business
Table 91. Allergan Latest Developments
Table 92. HRA Pharma Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 93. HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 94. HRA Pharma Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. HRA Pharma Main Business
Table 96. HRA Pharma Latest Developments
Table 97. Eurogine Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 98. Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 99. Eurogine Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Eurogine Main Business
Table 101. Eurogine Latest Developments
Table 102. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 103. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 104. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Main Business
Table 106. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Latest Developments
Table 107. Wuxi Tianyi Medical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 108. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 109. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Wuxi Tianyi Medical Equipment Co., Ltd. Main Business
Table 111. Wuxi Tianyi Medical Equipment Co., Ltd. Latest Developments
Table 112. SMB Corporation Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 113. SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 114. SMB Corporation Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. SMB Corporation Main Business
Table 116. SMB Corporation Latest Developments
Table 117. Shenyang Liren Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 118. Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 119. Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Shenyang Liren Main Business
Table 121. Shenyang Liren Latest Developments
Table 122. Tianjin Hejie Medical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 123. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 124. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Tianjin Hejie Medical Equipment Co., Ltd. Main Business
Table 126. Tianjin Hejie Medical Equipment Co., Ltd. Latest Developments
Table 127. Cooper Companies Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 128. Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 129. Cooper Companies Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Cooper Companies Main Business
Table 131. Cooper Companies Latest Developments
Table 132. AbbVie Allergan Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 133. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 134. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. AbbVie Allergan Main Business
Table 136. AbbVie Allergan Latest Developments
Table 137. Organon Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 138. Organon Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 139. Organon Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Organon Main Business
Table 141. Organon Latest Developments
Table 142. Shanghai Dahua Pharmaceutical Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 143. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 144. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Shanghai Dahua Pharmaceutical Main Business
Table 146. Shanghai Dahua Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-Acting Reversible Contraception(LARC)
Figure 2. Long-Acting Reversible Contraception(LARC) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-Acting Reversible Contraception(LARC) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-Acting Reversible Contraception(LARC) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-Acting Reversible Contraception(LARC) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-Acting Reversible Contraception(LARC) Sales Market Share by Country/Region (2025)
Figure 10. Long-Acting Reversible Contraception(LARC) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intrauterine Devices (IUCs)
Figure 12. Product Picture of Subcutaneous Implant
Figure 13. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type in 2026
Figure 14. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2021-2026)
Figure 15. Long-Acting Reversible Contraception(LARC) Consumed in Age 20~24 Years Old
Figure 16. Global Long-Acting Reversible Contraception(LARC) Market: Age 20~24 Years Old (2021-2026) & (K Units)
Figure 17. Long-Acting Reversible Contraception(LARC) Consumed in Age 25-34 Years Old
Figure 18. Global Long-Acting Reversible Contraception(LARC) Market: Age 25-34 Years Old (2021-2026) & (K Units)
Figure 19. Long-Acting Reversible Contraception(LARC) Consumed in Age 35~44 Years Old
Figure 20. Global Long-Acting Reversible Contraception(LARC) Market: Age 35~44 Years Old (2021-2026) & (K Units)
Figure 21. Long-Acting Reversible Contraception(LARC) Consumed in Other
Figure 22. Global Long-Acting Reversible Contraception(LARC) Market: Other (2021-2026) & (K Units)
Figure 23. Global Long-Acting Reversible Contraception(LARC) Sale Market Share by Application (2025)
Figure 24. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application in 2026
Figure 25. Long-Acting Reversible Contraception(LARC) Sales by Company in 2026 (K Units)
Figure 26. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company in 2026
Figure 27. Long-Acting Reversible Contraception(LARC) Revenue by Company in 2026 ($ millions)
Figure 28. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company in 2026
Figure 29. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Long-Acting Reversible Contraception(LARC) Sales 2021-2026 (K Units)
Figure 32. Americas Long-Acting Reversible Contraception(LARC) Revenue 2021-2026 ($ millions)
Figure 33. APAC Long-Acting Reversible Contraception(LARC) Sales 2021-2026 (K Units)
Figure 34. APAC Long-Acting Reversible Contraception(LARC) Revenue 2021-2026 ($ millions)
Figure 35. Europe Long-Acting Reversible Contraception(LARC) Sales 2021-2026 (K Units)
Figure 36. Europe Long-Acting Reversible Contraception(LARC) Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue 2021-2026 ($ millions)
Figure 39. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2026
Figure 40. Americas Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2021-2026)
Figure 41. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Figure 42. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2021-2026)
Figure 43. United States Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Region in 2026
Figure 48. APAC Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2021-2026)
Figure 49. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Figure 50. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2021-2026)
Figure 51. China Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 55. India Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2026
Figure 59. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2021-2026)
Figure 60. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Figure 61. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2021-2026)
Figure 62. Germany Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 63. France Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2021-2026)
Figure 70. Egypt Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Long-Acting Reversible Contraception(LARC) in 2026
Figure 76. Manufacturing Process Analysis of Long-Acting Reversible Contraception(LARC)
Figure 77. Industry Chain Structure of Long-Acting Reversible Contraception(LARC)
Figure 78. Channels of Distribution
Figure 79. Global Long-Acting Reversible Contraception(LARC) Sales Market Forecast by Region (2027-2032)
Figure 80. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Long-Acting Reversible Contraception(LARC)
Figure 2. Long-Acting Reversible Contraception(LARC) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-Acting Reversible Contraception(LARC) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-Acting Reversible Contraception(LARC) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-Acting Reversible Contraception(LARC) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-Acting Reversible Contraception(LARC) Sales Market Share by Country/Region (2025)
Figure 10. Long-Acting Reversible Contraception(LARC) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Intrauterine Devices (IUCs)
Figure 12. Product Picture of Subcutaneous Implant
Figure 13. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type in 2026
Figure 14. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2021-2026)
Figure 15. Long-Acting Reversible Contraception(LARC) Consumed in Age 20~24 Years Old
Figure 16. Global Long-Acting Reversible Contraception(LARC) Market: Age 20~24 Years Old (2021-2026) & (K Units)
Figure 17. Long-Acting Reversible Contraception(LARC) Consumed in Age 25-34 Years Old
Figure 18. Global Long-Acting Reversible Contraception(LARC) Market: Age 25-34 Years Old (2021-2026) & (K Units)
Figure 19. Long-Acting Reversible Contraception(LARC) Consumed in Age 35~44 Years Old
Figure 20. Global Long-Acting Reversible Contraception(LARC) Market: Age 35~44 Years Old (2021-2026) & (K Units)
Figure 21. Long-Acting Reversible Contraception(LARC) Consumed in Other
Figure 22. Global Long-Acting Reversible Contraception(LARC) Market: Other (2021-2026) & (K Units)
Figure 23. Global Long-Acting Reversible Contraception(LARC) Sale Market Share by Application (2025)
Figure 24. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application in 2026
Figure 25. Long-Acting Reversible Contraception(LARC) Sales by Company in 2026 (K Units)
Figure 26. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company in 2026
Figure 27. Long-Acting Reversible Contraception(LARC) Revenue by Company in 2026 ($ millions)
Figure 28. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company in 2026
Figure 29. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Long-Acting Reversible Contraception(LARC) Sales 2021-2026 (K Units)
Figure 32. Americas Long-Acting Reversible Contraception(LARC) Revenue 2021-2026 ($ millions)
Figure 33. APAC Long-Acting Reversible Contraception(LARC) Sales 2021-2026 (K Units)
Figure 34. APAC Long-Acting Reversible Contraception(LARC) Revenue 2021-2026 ($ millions)
Figure 35. Europe Long-Acting Reversible Contraception(LARC) Sales 2021-2026 (K Units)
Figure 36. Europe Long-Acting Reversible Contraception(LARC) Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue 2021-2026 ($ millions)
Figure 39. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2026
Figure 40. Americas Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2021-2026)
Figure 41. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Figure 42. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2021-2026)
Figure 43. United States Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Region in 2026
Figure 48. APAC Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2021-2026)
Figure 49. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Figure 50. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2021-2026)
Figure 51. China Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 55. India Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2026
Figure 59. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2021-2026)
Figure 60. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Figure 61. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2021-2026)
Figure 62. Germany Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 63. France Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2021-2026)
Figure 70. Egypt Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Long-Acting Reversible Contraception(LARC) Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Long-Acting Reversible Contraception(LARC) in 2026
Figure 76. Manufacturing Process Analysis of Long-Acting Reversible Contraception(LARC)
Figure 77. Industry Chain Structure of Long-Acting Reversible Contraception(LARC)
Figure 78. Channels of Distribution
Figure 79. Global Long-Acting Reversible Contraception(LARC) Sales Market Forecast by Region (2027-2032)
Figure 80. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Application (2027-2032)
